Search | Page 20 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

    ... in treating patients with hematologic cancer. Giving chemotherapy , such as fludarabine phosphate and cyclophosphamide, and ...

    Clinical Trial last updated 04/29/2016 - 12:48pm.

  2. Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant

    ... cancer to grow, which commonly do not respond to regular chemotherapy . Status:  ...

    Clinical Trial last updated 04/29/2016 - 10:38am.

  3. Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia in Complete Remission (QUAZAR AML-001)

    ... (CRi) following induction with or without consolidation chemotherapy . Subjects who have previously achieved CR/CRi with a ...

    Clinical Trial last updated 04/29/2016 - 8:39am.

  4. Vosaroxin and Azacitidine in Treating Patients With Myelodysplastic Syndromes

    ... patients with myelodysplastic syndromes. Drugs used in chemotherapy , such as vosaroxin and azacitidine, work in different ways to ...

    Clinical Trial last updated 04/28/2016 - 3:36pm.

  5. CPI-613 in Treating Patients With Myelodysplastic Syndromes Who Failed Previous Therapy

    ... who failed previous therapy. Sometimes when chemotherapy or biological therapy is given, it does not stop the growth of ...

    Clinical Trial last updated 04/28/2016 - 2:09pm.

  6. Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

    ... in treating patients with hematological cancer. Giving chemotherapy and total-body irradiation (TBI) before a donor umbilical cord ...

    Clinical Trial last updated 04/28/2016 - 1:52pm.

  7. Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

    ... peripheral blood stem cell transplant . Giving chemotherapy and total-body irradiation before a donor peripheral blood ...

    Clinical Trial last updated 04/28/2016 - 1:49pm.

  8. Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

    ... or does not respond to treatment. Drugs used in chemotherapy , such as filgrastim, cladribine, cytarabine, and mitoxantrone ...

    Clinical Trial last updated 04/28/2016 - 1:17pm.

  9. Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

    ... (MDS) that is likely to come back or spread. Giving chemotherapy drugs, such as fludarabine phosphate (FLU), and ...

    Clinical Trial last updated 04/28/2016 - 1:11pm.

  10. Treosulfan and Fludarabine Phosphate With or Without Total Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

    ... or acute myeloid leukemia. Giving chemotherapy , such as treosulfan and fludarabine phosphate, and total-body ...

    Clinical Trial last updated 04/28/2016 - 1:05pm.